Endothelial progenitor cells and a stromal cell-derived factor-1a analogue synergistically improve survival in sepsis.
Endothelial progenitor cells and a stromal cell-derived factor-1a analogue synergistically improve survival in sepsis. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1509-19.